FTC Sues Prescription Drug Middlemen for Artificially Inflating …
Sep 20, 2024 · Caremark, Express Scripts, Optum, and their affiliates created a broken rebate system that inflated insulin drug prices, boosting PBM profits at the expense of vulnerable patients, the FTC alleges
FTC Releases Second Interim Staff Report on Prescription Drug …
Jan 14, 2025 · The Federal Trade Commission today published a second interim staff report on the prescription drug middleman industry, ... Express Scripts, Inc. (ESI), and OptumRx, Inc. (OptumRx)—marked up numerous specialty generic drugs dispensed at their affiliated pharmacies by thousands of percent, and many others by hundreds of percent. Such ...
Caremark Rx, Zinc Health Services, et al., In the Matter of (Insulin)
Sep 20, 2024 · The FTC filed a lawsuit against the three largest prescription drug benefit managers (PBMs)—Caremark Rx, Express Scripts (ESI), and OptumRx—and their affiliated group purchasing organizations (GPOs) for engaging in anticompetitive and unfair rebating practices that have artificially inflated the list price of insulin drugs.
Express Scripts sues FTC over drug pricing report | Reuters
Sep 17, 2024 · Pharmacy benefit manager Express Scripts sued the U.S. Federal Trade Commission on Tuesday over the regulator's recent drug pricing report, calling the report's conclusion that the...
Express Scripts sues FTC over report on high drug prices - The Hill
Sep 17, 2024 · Express Scripts, one of the country’s largest pharmacy benefit managers, sued the Federal Trade Commission (FTC) Tuesday and demanded the agency retract a report saying the industry middlemen...
Express Scripts sues FTC over drug pricing report
Sep 17, 2024 · Pharmacy benefit manager Express Scripts sued the U.S. Federal Trade Commission on Tuesday over the regulator's recent drug pricing report, calling the report's conclusion that the...
FTC releases second report slamming pharmacy benefit managers
Jan 14, 2025 · The FTC looked at all specialty generic drugs dispensed from 2017 to 2022 for people in commercial health plans and Medicare prescription drug plans managed by Caremark, Optum Rx and Express Scripts.
FTC: Big 3 PBMs generated $7.3B from specialty generic markups
Jan 14, 2025 · The FTC’s findings—which analyzed 51 specialty generic drugs from 2017 to 2022—showed these pharmacy benefit managers’ (PBMs') affiliated pharmacies spun up $7.3 billion in excess revenue ...
Express Scripts Sues FTC, Demands Withdrawal of PBM Report
Sep 17, 2024 · For more than two years, Express Scripts fully cooperated with the FTC study into the PBM industry, meeting the agency's extensive demands for data and information. The FTC's report...
Express Scripts sues FTC over report about pharmacy benefit
Sep 17, 2024 · Cigna's Express Scripts filed a lawsuit Tuesday challenging a federal report that places the blame for rising drug prices on pharmacy benefit managers, describing it as "seventy-four pages of unsupported innuendo" and calling for a retraction.